Glucose polymers for peritoneal dialysis

US11498939B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11498939-B2
Application numberUS-201716332169-A
CountryUS
Kind codeB2
Filing dateSep 14, 2017
Priority dateSep 15, 2016
Publication dateNov 15, 2022
Grant dateNov 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a novel glucose polymer which is particularly useful for administration by the parenteral route, and to the method for the production thereof. The invention also relates to compositions comprising such a glucose polymer, and to the methods for the production thereof. The invention further relates to the use thereof as a medicament, for example as an osmotic agent for peritoneal dialysis.

First claim

Opening claim text (preview).

The invention claimed is: 1. A glucose polymer characterized in that it is obtained by branching and reduction of a starch having an amylose content of at least 10%, and in that said glucose polymer has an α-1,6-bond content of less than 20%, a weight-average molecular weight (Mw) less than 50,000 Da, this Mw being determined by liquid chromatography and detection by differential refractometry, and a polydispersity index (polyD) of less than 3.0 and greater than 0.5; and wherein reduction results in the conversion of carbonyl groups to hydroxyl groups, and in that it has a reducing sugar content of less than 0.5%, this percentage being expressed by dry weight of reducing sugars relative to the total dry weight of the glucose polymer. 2. The glucose polymer as claimed in claim 1 , characterized in that said glucose polymer has an α-1,6-bond content of greater than 7%. 3. The glucose polymer as claimed in claim 1 , characterized in that said starch has an amylose content of at least 20%. 4. The glucose polymer as claimed in claim 1 , characterized in that it has a weight-average molecular weight (Mw) chosen in the range of from 20,000 to 50,000 daltons (Da); this Mw being determined by liquid chromatography and detection by differential refractometry. 5. The glucose polymer as claimed in claim 1 , characterized in that it has a pH, after sterilization at 121° C. for 45 minutes, in a range of from 6 to 8, when it is formulated as an aqueous 5% solution. 6. The glucose polymer as claimed in claim 1 , characterized in that it has an osmolality of between 200 and 300 mOsm/kg; when it is formulated as a 0.4% solution. 7. The glucose polymer as claimed in claim 1 , characterized in that it has a reducing sugar content of less than 0.1%, this percentage being expressed by dry weight of reducing sugars relative to the total dry weight of the glucose polymer. 8. The glucose polymer as claimed in claim 1 , characterized in that it is soluble to very soluble in water when it is at ambient temperature. 9. The glucose polymer as claimed in claim 1 , characterized in that it is not substituted. 10. A composition, comprising the polymer as defined claim 1 . 11. The composition as claimed in claim 10 , characterized in that it is a solution. 12. The glucose polymer as claimed in claim 1 or the composition as claimed in claim 11 , for use thereof as a medicament. 13. The glucose polymer as claimed in claim 1 or the composition as claimed in claim 11 , for use thereof in peritoneal dialysis, and/or parenteral nutrition, and/or in plasma filling, and/or as an osmotic agent, and/or as a plasma expander, and/or in vaccinology, and/or as an adjuvant, and/or as a protein stabilizer, and/or as a protein carrier. 14. A method for producing a composition as defined in claim 10 , which comprises mixing a polymer as defined in claim 1 with at least one other substance and/or a solvent. 15. A method for producing a glucose polymer as defined in claim 1 , which comprises subjecting a starch having an amylose content of at least 10% to: (a) a branching step; and (b) a reduction step.

Assignees

Inventors

Classifications

  • Starch or degraded starch, e.g. amylose, amylopectin · CPC title

  • Preparation of derivatives of amylose · CPC title

  • containing gelling or thickening agents (marmalades, jams, jellies or other similar fruit or vegetable compositions A23L21/10) · CPC title

  • using additives (addition of substantially indigestible substances A23L33/21) · CPC title

  • C07H3/00Primary

    Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (preparation by hydrolysis of di-or polysaccharides C13; separation or purification of sucrose, glucose, fructose, lactose or maltose C13) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11498939B2 cover?
The invention relates to a novel glucose polymer which is particularly useful for administration by the parenteral route, and to the method for the production thereof. The invention also relates to compositions comprising such a glucose polymer, and to the methods for the production thereof. The invention further relates to the use thereof as a medicament, for example as an osmotic agent for pe…
Who is the assignee on this patent?
Roquette Freres
What technology area does this patent fall under?
Primary CPC classification C07H3/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).